USP25 and platelet hyperreactivity in aging
therapy may affect the prognostic implication of CTC-high at diagnosis.The authors demonstrated that sustained MRD negativity may overcome the prognostic implication of CTC-high.These data suggest that sequential testing may allow physicians to tailor therapy based on this biomarker.Alas, this was not addressed in this study and will need to await further studies.
Authors
- Pavel Davizon‐Castillo (ORCID: https://orcid.org/0000-0002-3677-4476)
- John Hwa
Institutions
- University of Washington (US)
- Center for Cancer and Blood Disorders (US)
- Cardiovascular Research Center (BR)
- University of Diyala (IQ)
Publication Details
- Journal
- Blood
- Published
- 2026-01-22
- DOI
- https://doi.org/10.1182/blood.2025031416
- Primary Topic
- Ubiquitin and proteasome pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00